Abstract
The S100A8/S100A9 heterodimer, commonly referred to as calprotectin (CP), is a member of the S100 subfamily of EF-hand calcium binding proteins that is largely expressed in activated monocytes and macrophages and has well-defined functions in acute and chronic inflammation. Indeed, certain S100 proteins including S100A8/A9 are exported from cells by an as-yet unknown mechanism. Once outside the cell, S100A8/A9 activates cell surface receptors such as the receptor for advanced glycation end products (RAGE) and has also been shown to inhibit the growth of pathogenic bacteria through the chelation of trace metal ions such as zinc (Zn2+) and manganese (Mn2+). The binding of these metal ions by S100A8/A9 has also been shown to induce apoptosis in various tumor cell lines. However, several lines of evidence have suggested that S100A8/A9-dependent apoptosis is not solely due to its ability to sequester Zn2+ from cells. Rather, it appears that trace metal binding to S100A8/A9 triggers a novel conformational switch in the protein, which promotes binding to specific sites on the surface of cells or through interaction with yet unidentified cell surface receptors. This review summarizes what is currently known regarding the molecular mechanisms by which S100A8/A9 performs its role as a novel apoptotic agent.
Keywords: S100A8/A9, calprotectin, apoptosis, zinc
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Apoptosis-Inducing Activity of the S100A8/A9 Heterodimer
Volume: 8 Issue: 4
Author(s): Mohammad Hashemi, Seth Chitayat, Sudharsana Rao Ande and Walter J. Chazin
Affiliation:
Keywords: S100A8/A9, calprotectin, apoptosis, zinc
Abstract: The S100A8/S100A9 heterodimer, commonly referred to as calprotectin (CP), is a member of the S100 subfamily of EF-hand calcium binding proteins that is largely expressed in activated monocytes and macrophages and has well-defined functions in acute and chronic inflammation. Indeed, certain S100 proteins including S100A8/A9 are exported from cells by an as-yet unknown mechanism. Once outside the cell, S100A8/A9 activates cell surface receptors such as the receptor for advanced glycation end products (RAGE) and has also been shown to inhibit the growth of pathogenic bacteria through the chelation of trace metal ions such as zinc (Zn2+) and manganese (Mn2+). The binding of these metal ions by S100A8/A9 has also been shown to induce apoptosis in various tumor cell lines. However, several lines of evidence have suggested that S100A8/A9-dependent apoptosis is not solely due to its ability to sequester Zn2+ from cells. Rather, it appears that trace metal binding to S100A8/A9 triggers a novel conformational switch in the protein, which promotes binding to specific sites on the surface of cells or through interaction with yet unidentified cell surface receptors. This review summarizes what is currently known regarding the molecular mechanisms by which S100A8/A9 performs its role as a novel apoptotic agent.
Export Options
About this article
Cite this article as:
Hashemi Mohammad, Chitayat Seth, Ande Rao Sudharsana and Chazin J. Walter, Apoptosis-Inducing Activity of the S100A8/A9 Heterodimer, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2009; 8 (4) . https://dx.doi.org/10.2174/187152309789838993
DOI https://dx.doi.org/10.2174/187152309789838993 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
EDITORIAL (Thematic Issue: Serpins as Therapeutics – A Potential Biologic Source for Unique Protein-based Therapeutics)
Cardiovascular & Hematological Disorders-Drug Targets Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds
Endocrine, Metabolic & Immune Disorders - Drug Targets Clopidogrel and Aspirin in Cardiovascular Medicine: Responders or Not -- Current Best Available Evidence
Cardiovascular & Hematological Agents in Medicinal Chemistry Current Research on Opioid Receptor Function
Current Drug Targets Characterization of the Clinical and Laboratory Features of Primary and Secondary Antiphospholipid Syndrome in a Cohort of Egyptian Patients
Current Rheumatology Reviews Anti-Endothelial Cell Antibodies in Patients with Cerebral Small Vessel Disease
Current Neurovascular Research RAGE: A Single Receptor for Several Ligands and Different Cellular Responses: The Case of Certain S100 Proteins
Current Molecular Medicine Astrocyte`s RAGE: More Than Just a Question of Mood
Central Nervous System Agents in Medicinal Chemistry Reduction of eNOS in Vascular Smooth Muscle by Salt Independently of Hypertension
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Simple and Rapid Method for Expression and Purification of Functional TNF-α Using GST Fusion System
Current Pharmaceutical Biotechnology Pulmonary Hypertension: Clinical Presentation, Diagnosis, Treatment,and Dana Point World Symposium Highlights
Current Respiratory Medicine Reviews Targeting Chemoattractant Receptors in Allergic Inflammation
Current Drug Targets - Inflammation & Allergy COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Current Rheumatology Reviews Modulation of Eosinophil Functions by Nitric Oxide: Cyclic GMPdependent and -independent Mechanisms
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Omalizumab for Asthma: Indications, Off-Label Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Features of Bioaccumulation and Toxic Effects of Copper (II) Oxide Nanoparticles Under Repeated Oral Exposure in Rats
Pharmaceutical Nanotechnology Intraocular Immune Mechanisms in Uveitis
Current Immunology Reviews (Discontinued) Interstitial Lung Disease in Rheumatoid Arthritis
Current Rheumatology Reviews Hypotensive Natural Products: Current Status
Mini-Reviews in Medicinal Chemistry Soluble RAGE-Modulating Drugs: State-of-the-Art and Future Perspectives for Targeting Vascular Inflammation
Current Vascular Pharmacology